First Financial Corp’s Teva Pharmaceuticals TEVA Stock Holding History

First Financial Corp’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-279	Closed	-$3K	–	363
2019 Q4	$3K	Hold	279	–	–	﹤0.01%	356
2019 Q3	$2K	Buy	+279	New	+$2.14K	﹤0.01%	376
2019 Q2	–	Sell	-170	Closed	-$3K	–	319
2019 Q1	$3K	Hold	170	–	–	﹤0.01%	309
2018 Q4	$3K	Hold	170	–	–	﹤0.01%	309
2018 Q3	$4K	Sell	170 -100	-37%	-$2.32K	﹤0.01%	316
2018 Q2	$6K	Hold	270	–	–	﹤0.01%	318
2018 Q1	$5K	Sell	270 -125	-32%	-$2.44K	﹤0.01%	328
2017 Q4	$8K	Sell	395 -231	-37%	-$3.48K	0.01%	334
2017 Q3	$11K	Sell	626 -285	-31%	-$6.41K	0.01%	339
2017 Q2	$30K	Hold	911	–	–	0.02%	269
2017 Q1	$29K	Sell	911 -512	-36%	-$17.5K	0.02%	282
2016 Q4	$52K	Sell	1,423 -10	-0.7%	-$399	0.03%	214
2016 Q3	$66K	Sell	1,433 -611	-30%	-$31.9K	0.04%	193
2016 Q2	$103K	Sell	2,044 -585	-22%	-$31.1K	0.06%	168
2016 Q1	$140K	Hold	2,629	–	–	0.07%	171
2015 Q4	$172K	Sell	2,629 -90	-3%	-$5.56K	0.09%	157
2015 Q3	$154K	Hold	2,719	–	–	0.09%	160
2015 Q2	$161K	Sell	2,719 -30	-1%	-$1.85K	0.08%	163
2015 Q1	$171K	Hold	2,749	–	–	0.09%	161
2014 Q4	$158K	Sell	2,749 -98	-3%	-$5.46K	0.08%	164
2014 Q3	$154K	Sell	2,847 -325	-10%	-$17.2K	0.08%	167
2014 Q2	$166K	Sell	3,172 -255	-7%	-$13K	0.08%	170
2014 Q1	$181K	Sell	3,427 -755	-18%	-$34.9K	0.09%	163
2013 Q4	$168K	Sell	4,182 -1,039	-20%	-$40.9K	0.08%	168
2013 Q3	$197K	Sell	5,221 -835	-14%	-$32.6K	0.1%	161
2013 Q2	$237K	Buy	+6,056	New	+$236K	0.12%	149

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

First Financial Corp's TEVA Position: Q1 2020 in Review

First Financial Corp sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 279 shares — an estimated $3K sold.

First Financial Corp first reported a position in TEVA in Q2 2013 and held it in 26 quarters. The position peaked at $237K in Q2 2013. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

First Financial Corp reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
First Financial Corp sold 279 Teva Pharmaceuticals shares in Q1 2020, an estimated $3K.
First Financial Corp first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 26 quarters.
First Financial Corp's Teva Pharmaceuticals position peaked at $237K in Q2 2013.
459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on First Financial Corp's 13F filing for Q1 2020, filed 15 Apr 2020.